My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 79

    1.

    Mammaglobin as a potential molecular target for breast cancer drug delivery.

    Zuo L, Li L, Wang Q, Fleming TP, You S.

    Cancer Cell Int. 2009 Mar 23;9:8.PMID: 19309500 [PubMed]Related articlesFree article

    2.

    Mammaglobin-based strategies for treatment of breast cancer.

    Goedegebuure PS, Watson MA, Viehl CT, Fleming TP.

    Curr Cancer Drug Targets. 2004 Sep;4(6):531-42. Review.PMID: 15462037 [PubMed - indexed for MEDLINE]Related articles

    3.

    Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival.

    ten Haaf A, Bektas N, von Serenyi S, Losen I, Arweiler EC, Hartmann A, Knüchel R, Dahl E.

    BMC Cancer. 2009 Aug 25;9:298.PMID: 19706168 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.

    Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W, Yuan Z.

    BMC Cancer. 2009 Apr 1;9:102.PMID: 19338666 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.

    Whelan SA, Lu M, He J, Yan W, Saxton RE, Faull KF, Whitelegge JP, Chang HR.

    J Proteome Res. 2009 Aug;8(8):4151-60.PMID: 19522481 [PubMed - indexed for MEDLINE]Related articles

    6.

    Access of viral proteins to mitochondria via mitochondria-associated membranes.

    Williamson CD, Colberg-Poley AM.

    Rev Med Virol. 2009 May;19(3):147-64. Review.PMID: 19367604 [PubMed - indexed for MEDLINE]Related articles

    7.

    siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells.

    Dong X, Liu A, Zer C, Feng J, Zhen Z, Yang M, Zhong L.

    BMC Cancer. 2009 May 5;9:133.PMID: 19416503 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.

    Aroui S, Brahim S, De Waard M, Bréard J, Kenani A.

    Cancer Lett. 2009 Nov 18;285(1):28-38. Epub 2009 Jun 11.PMID: 19523755 [PubMed - indexed for MEDLINE]Related articles

    9.

    Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy.

    Acharya S, Dilnawaz F, Sahoo SK.

    Biomaterials. 2009 Oct;30(29):5737-50. Epub 2009 Jul 23.PMID: 19631377 [PubMed - indexed for MEDLINE]Related articles

    10.

    Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer.

    Jörissen H, Bektas N, Dahl E, Hartmann A, ten Haaf A, Di Fiore S, Kiefer H, Thess A, Barth S, Klockenbring T.

    BMC Cancer. 2009 Jun 24;9:200.PMID: 19552806 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    JAM-A expression positively correlates with poor prognosis in breast cancer patients.

    McSherry EA, McGee SF, Jirstrom K, Doyle EM, Brennan DJ, Landberg G, Dervan PA, Hopkins AM, Gallagher WM.

    Int J Cancer. 2009 Sep 15;125(6):1343-51.PMID: 19533747 [PubMed - indexed for MEDLINE]Related articles

    12.

    Kv1.3 voltage-gated K(+) channel subunit as a potential diagnostic marker and therapeutic target for breast cancer.

    Jang SH, Kang KS, Ryu PD, Lee SY.

    BMB Rep. 2009 Aug 31;42(8):535-9.PMID: 19712592 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.

    Saleh EM, El-Awady RA, Abdel Alim MA, Abdel Wahab AH.

    Cell Biochem Biophys. 2009;55(2):95-105. Epub 2009 Jul 11.PMID: 19593673 [PubMed - indexed for MEDLINE]Related articles

    15.

    The subcellular localization of IGFBP5 affects its cell growth and migration functions in breast cancer.

    Akkiprik M, Hu L, Sahin A, Hao X, Zhang W.

    BMC Cancer. 2009 Apr 3;9:103.PMID: 19341485 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    CIP2A is associated with human breast cancer aggressivity.

    Côme C, Laine A, Chanrion M, Edgren H, Mattila E, Liu X, Jonkers J, Ivaska J, Isola J, Darbon JM, Kallioniemi O, Thézenas S, Westermarck J.

    Clin Cancer Res. 2009 Aug 15;15(16):5092-100. Epub 2009 Aug 11.PMID: 19671842 [PubMed - indexed for MEDLINE]Related articles

    17.

    Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.

    Wiradharma N, Tong YW, Yang YY.

    Biomaterials. 2009 Jun;30(17):3100-9. Epub 2009 Apr 1.PMID: 19342093 [PubMed - indexed for MEDLINE]Related articles

    18.

    Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph node metastasis.

    Raica M, Cîmpean AM, Meche A, Alexa A, Suciu C, Mureşan A.

    Rom J Morphol Embryol. 2009;50(3):341-7.PMID: 19690758 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent.

    Agarwal A, Gupta U, Asthana A, Jain NK.

    Biomaterials. 2009 Jul;30(21):3588-96. Epub 2009 Apr 2.PMID: 19344947 [PubMed - indexed for MEDLINE]Related articles

    20.

    Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies.

    Frank RT, Edmiston M, Kendall SE, Najbauer J, Cheung CW, Kassa T, Metz MZ, Kim SU, Glackin CA, Wu AM, Yazaki PJ, Aboody KS.

    PLoS One. 2009 Dec 15;4(12):e8314.PMID: 20016813 [PubMed - in process]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk